Oxidative stress appears to play a role in the pathogenesis of several infl ammatory gastrointestinal diseases. Increased homocysteine levels may play a role in the pathogenesis of Chron's disease and ulcerative colitis. The aim of this study was to examine the infl uence of homocysteine on the antioxidant status of rat intestine and liver. The levels of thiobarbituric acid reactive substances (TBARS), activity of catalase (CAT) and total antioxidant status (TAS) were investigated in the isolated gut and liver of young male rats in the control group (8 rats) and after 3-hоur incubation in high doses of D, L-homocysteine thionolactone (Hcy) (10 μmol/L) (8 rats). Samples of duodenum, ileum, colon and liver were homogenized in sodium phosphate buffer (1:10). Homogenates were centrifuged at 10000 for 10 min at 4 0 C and the supernatant was taken for biochemical assays. Our results showed that high D, L-homocysteine thionolactone concentration reduced enzymatic catalase activity in homogenates of the isolated segments of duodenum (27.04%) p<0.01; ileum (37.27%), colon (34.17%) and liver (67.46%) p<0.001. Exposition to high D,L-homocysteine thiolactone concentration signifi cantly increased TBARS levels in the duodenum (106.05%), ileum (47.24%), colon (112.75%) and liver (32.07%) (p<0.01). Homocysteine also modifi ed the total antioxidant status of homogenates from the duodenum, ileum, colon and liver, increasing by 20.68% (duodenum), 24.74% (ileum), 14.88% (colon) and 19.35% (liver) (p<0.001). Homocysteine induced a consistent oxidative stress in rat's intestine and liver (reduced activity of catalase and increased level of TBARS), but the elevated activity of TAS in our experiments could be explained as an adaptive response to the generated free radicals which indicates the failure of the total antioxidant defense mechanism to protect the tissues from damage caused by homocysteine.
INTRODUCTION
Oxidative stress due to the production of intracellular and extracellular reactive oxygen species may be a major player in the pathogenesis of cardiovascular and other diseases. It is now well established that hyperhomocysteinemia is an independent risk factor for coronary artery diseases, cerebrovascular diseases, and peripheral vascular occlusive diseases. Tissue accumulation of homocysteine (Hcy) occurs in homocystinuria, a metabolic disease characterized by defi ciency of cystathionine b-synthase and by mental retardation, vascular problems, skeletal abnormalities, and hepatic compromise, with fatty accumulation and cirrhosis [1] .
Oxidative stress appears to play a role in the pathogenesis of several infl ammatory gastrointestinal diseases [2, 3] . Changes in intestinal motility have been reported in different models of intestinal infl ammation. The initiating factor of altered motility could be an alteration of gut redox status. Increased homocysteine levels in the colonic mucosa and plasma of patients with infl ammatory bowel disease (IBD) may play a role in the pathogenesis of Chron's disease and ulcerative colitis. Homocysteine is also known to aggravate the pathogenesis of IBD. Interestingly, the colon is the pivot site that regulates Hcy levels in the plasma.
Milton et al. [4] showed that homocysteine inhibited hydrogen peroxide breakdown by catalase (CAT) in the human neuroblastoma cell line. Matte et al. [5] showed that homocysteine induced oxidative stress in rat liver. Streck et al. [6] demonstrated that homocysteine signifi cantly increased thiobarbituric acid-reactive substances (TBARS), but did not change antioxidant enzymes. Their results suggest that oxidative stress is involved in the neurological dysfunction of homocystinuria in the rat hippocampus.
Catalase, an antioxidant enzyme responsible for the degradation of hydrogen peroxide, is protective in many diseases. The amino-acid homocysteine has been suggested to be a pro-oxidant with elevated levels linked to the oxidative stress seen in Alzheimer's and other diseases. This study shows that homocysteine inhibits the breakdown of hydrogen peroxide [7] .
The aim of this study was to examine the infl uence of high level of homocysteine on the antioxidant status of rat intestine tissue (duodenum, ileum, colon) and liver. In the present study, the effects of acute administration of homocysteine thionolactone (metabolite of homocysteine) on the formation of TBARS, total antioxidant status (TAS) and CAT activity were investigated. All chemicals were obtained from Sigma Chemical Co., St. Louis, MO, USA. Rats, aged 20-21 weeks and weighing 160±200 g were anesthetized with ketamine 4mg/kg body mass. After cervical dislocation the gastrointestinal tract and liver were quickly removed and processed as follows. Group I (control, n=8) (duodenum, ileum, colon) and liver were kept in Tyrode's solution, group II (experimental, n=8) were in Tyrode's solution with homocysteine (10 μmol/L). Both groups were incubated for three hours. After completion of the treatment period, the tissues were homogenized in 10 ml (1:10) of 50 mM sodium phosphate buffer, pH 7.0. Homogenates were centrifuged at 13000 for 10 min. at 4 0 C to discard nuclei and cell debris. The supernatant was taken for biochemical assays. The homogenates used were from individual animals and they were not pooled.
MATERIAL AND METHODS

Wistar
Protein contents were measured according to the method of Bratford [8] using bovine serum albumin as standard.
Catalase assay
Catalase (Cat) activity was determined based on the spectrophotometric measurement according to Aebi [9] . This method was based on the disappearance of H 2 O 2 at 240 nm in the reaction medium containing 30 mM H 2 O 2 , 50 mmol/L potassium phosphate buffer pH 7.0 and 0.1 ml sample Cat activity expressed as micromoles of hydrogen peroxide decomposed /min /mg protein.
Lipid peroxidation
Lipid peroxidation (LPO) was measured in tissue homogenates according to the method of Ohkawa et al. [10] . Briefl y, 25 μl homogenates, 975 μl TRIS buffer pH 7.0 and 2 ml TBA reagent were added into glass tubes. The mixture was vortexed and reaction was carried out in a boiling water bath for 1 h. The mixture was allowed to cool in water for 5 min. and was centrifuged at 750 x g for 10 min at 25 0 C. The obtained resulting pink stained TBARS were determined at 535 nm (ULTROSPECT 2000, Pharmacia biotech). The measurement was based on the formation of thiobarbituric acid-reactive substances (TBARS) and expressed as the extent of MDA production. TBARS were calculated as μmol TBARS /mg protein.
Tissue total antioxidant status (TAS)
TAS was measured on Ultrospect 2000 Analyzer with Randox reagent set (Randox). The determination was based on the reaction of 2,2 , -azino-di-(3-ethylbenythiazoline sulfonate) (ABTS + ) with peroxidase (metmyoglobin) and H 2 O 2 to produce the radical cation ABTS + [11] . For the total antioxidant assay, 2,2-azinobis-(3-ethyl-benzothiazoline-6-sulfonic acid) (Sigma-Aldrich) was dissolved in deionized water to a 7 mM concentration.
The ABTS radical cation (ABTS + ) was produced by reacting the ABTS stock solution with 2.45 mM potassium persulfate (fi nal concentration) and incubating the solution in the dark at room temperature for 12-16 h before use. The radical stock solution was diluted with a 5 mM solution of phosphate-buffered saline (PBS; pH 7.4) to obtain a spectrophotometric absorbance value of 0.700 ± 0.020 at 734 nm. Trolox (a Vitamin E analogue) standards (Calbiochem) were prepared in PBS over the range 0-15 μM. For the standardization of the starting point of all assays and standards, a 10 μl sample/Trolox standard was added to 1 ml ABTS ± solution (A 734 nm=0.700± 0.020) and an absorbance reading taken exactly 1 min after initial mixing until the decrease in absorbance ceased. Assays were performed in triplicate and validations were performed against PBS to confi rm that extraction buffer components did not interfere with the analysis.
The antioxidant activity was expressed as the rate of decrease in absorbance (min/mg protein) and as the mean of three replicate samples.
Statistical analysis
Results were analyzed by standard statistical methods, expressed as mean ± SD and graphically presented (Statistical program GraphPad Prism 6). Signifi cance of the differences between the experimental and control groups was determined by Student's t-test. Differences were considered signifi cant at p< 0.05.
RESULTS
Catalase activity, TBARS and TAS in isolated segments of duodenum, ileum, colon and liver incubated in Tyrode ,, s solution during 3 hours
The summary of the main characteristics of control values of oxidative stress parameters (catalase activity, TBARS and TAS concentration) are presented in Table I .
Catalase activity showed the highest value in the liver (347.63 ± 60.11 U/mg protein), the lowest value in the duodenum (166.50 ± 10.44 U/mg protein). There was a statistically signifi cant difference between values in liver and other organs of gastrointestinal tract. Also the differences were found between other organs: duodenum -D; ileum -I, colon -C were signifi cant (D/I p<0.01; D/C p<0.01; D/L p<0.05; I/C not signifi cant ; I/L p<0.01, C/L p<0.05).
TBARS concentration was the highest in the liver (2.43 ± 0.1 μmol/mg protein), the lowest in duodenum (0.92 ± 0.23 μmol/mg protein). There was a statistically signifi cant difference between control values in the liver and other examined organs ((P< 0.001), but the difference between the duodenum, ileum and colon were not signifi cant (D/I not signifi cant; D/C not signifi cant; D/L p<0,001; I/C not signifi cant; I/L p<0,001, C/L p<0,001).
TAS values were the highest the duodenum (7.24 ± 0.45(mmol Trolox/mg protein), statistically signifi cantly higher compared to the ileum, colon and liver. D/I p<0.05; D/C p<0.05; D/L p<0.05. There were no signifi cant differences between the values in the other three organs (I/C not signifi cant; I/L not signifi cant, C/L not signifi cant). Catalase activity, TBARS and TAS in isolated segments of duodenum, ileum, colon and liver incubated in homocysteine (10 μmol/L) during 3 hours
Incubation in D,L-homocysteine thionolactone during 3 hours showed a signifi cant infl uence on antioxidant defenses and lipid peroxidation in all examined organs Table I. CAT activity was reduced in all investigated organs, maximum decrease was observed in the ileum and liver. In absolute values the highest activity of catalase was observed in the ileum (203,502 U/mg protein) and the lowest in the liver (113.13 U/mg protein).
In Fig. 1 are presented control values and the reduction of catalase activity after incubation in D,L homocysteine thionolactone (it varied from 27.04 % in duodenum to 67.6% in liver). All the values were signifi cantly different compared to the control group p<0.01, but the differences between the organs were signifi cant too: (D/I p<0,05; D/C not signifi cant; D/L not signifi cant; I/C not signifi cant; I/L p<0,05, C/L not signifi cant).
In Fig F. 2 are presented the levels of TBARS. The highest level of TBARS was observed in the liver (3.21 μmol/mg protein, while in the ileum was the lowest (1.62 μmol/ mg protein). Highest increase compared to the control group was observed in colon (112.76%), the lowest in liver (32.07%). All the values were signifi cantly different 
DISCUSSION
In the present study, the effects of acute administration of D,L-homocysteine thiolactone on non-enzymatic and enzymatic antioxidant defenses were investigated in an in vitro animal model of rat duodenum, ileum, colon and liver. Incubation of tissues in high D,L-homocysteine thiolactone concentration reduced enzymatic CAT activity in the duodenum, ileum, colon and liver compared to the control group. A signifi cant inhibition of hepatic CAT activity and intestinal CAT activity in rat organs incubated in homocysteine was also verifi ed in literature [12, 13] . Other studies suggested a negative correlation between plasma Hcy levels and CAT activity in the liver of rats, indicating a signifi cant reduction of hepatic antioxidant defense [13, 14] . We observed a signifi cant inhibition of hepatic CAT activity in hyperhomocysteinemic rats. In agreement with our data, other studies suggest a negative correlation between plasma Hcy levels and CAT activity in the liver of rats, pointing a signifi cant reduction of hepatic antioxidant defense [15, 16] . The results from this study show that homocysteine can act directly on catalase and inhibit the breakdown of H 2 O 2 . The suggestion that homocysteine can itself generate H 2 O 2 , with the assistance of copper, has provided a proposed mechanism for this contribution.
Exposition to high D,L-homocysteine thiolactone concentrations signifi cantly increased TBARS levels in the duodenum, ileum, colon and liver. Kolling et al. [17] showed that Hcy increased lipid peroxidation and TBARS level in rats' heart. Lipid peroxidation was also observed in the liver of rats, and was associated with Hcyinduced cell injury, including apoptosis and infl ammation in liver disease [12, 13] .
Hepatic lipid peroxidation appears to be strongly associated with Hcy levels [18] .
Similar results reported Matte et al. [5] . They showed the occurrence of oxidative stress and notably reduced antioxidant defenses (enzymatic and non-enzymatic) and increased lipid peroxidation, and infl ammatory infi ltration in the liver of Hcy-treated rats.
TAS is a more useful index of antioxidant status because it considers not only the quantity, but also the reactivity of antioxidants. Our results showed that Hcy increased the total antioxidant status of homogenates from the duodenum, ileum, colon and liver suggesting that this amino acid causes the acute increase of quantity of nonenzymatic antioxidants in the liver and intestine.
The elevated activity of TAS is due to the adaptive response to generated free radicals, indicating the failure of the total antioxidant defense mechanism to protect the tissues from mechanical damage caused by homocysteine, as evidenced by lipid peroxidation.
According to our fi ndings, homocysteine, during exposition, directly inhibited catalase activity, activated the process of lipid peroxidation and elevated total antioxidant status in the isolated intestine and liver. The observed increase in lipid peroxidation and TAS suggests the presence of oxidative stress in the gastrointestinal system.
A correlation between oxidative stress and high levels of homocysteine has been demonstrated in vascular smooth muscle cells [19] . Homocysteine inhibits endothelium-dependent NO-mediated dilation in the porcine retinal arterioles by producing superoxide from NAD(P)H oxidase [20] .
Although the present study only concerns the acute effects of Hcy on oxidative stress parameters in rats, it is tempting to consider the reported prooxidant effects of Hcy on the gastrointestinal system in animals and humans. It is proposed that chronic oxidative stress contributes to the pathogenesis of some infl ammatory digestive diseases. Reactive oxygen species (ROS) are produced within the gastrointestinal (GI) tract, but their roles in the pathophysiology and disease pathogenesis have not been well studied. Elevated levels of plasma homocysteine have been implicated in infl ammation and remodeling of the intestinal vasculature, and Hcy is also known to aggravate the pathogenesis of infl ammatory bowel disease (IBD), Chron's, disease, ulcerative colitis, etc. Interestingly, the colon is the pivot site that regulates Hcy levels in the plasma. Levels of ROS, superoxide, and inducible nitric oxide were elevated in hyperhomocysteinemia. A large number of literature data indicates that oxidative stress correlates with the level of homocysteine in diseases of the digestive tract [21] . Early identifi cation of hyperhomocysteinemia and markers of oxidative stress may reduce the progression of some gastrointestinal diseases and their complications such as infl ammatory bowel disease, Crohn's disease, ulcerative colitis and susceptibility to thrombotic events [21] .
Low erythrocyte catalase enzyme activity was found to correlate with high serum total homocysteine levels in Tunisian patients with acute myocardial infarction. Hyperhomocysteinemia may increase the myocardial wall dysfunction by excessive production of reactive oxygen species which is made evident by increased lipid peroxidation [22] [23] [24] .
During chronic exposition to high levels of homocysteine, the patients with diabetes mellitus, cardiovascular disease and gastrointestinal disease, obesity and metabolic syndrome showed decreased levels of TAS [25] .
The signifi cant correlation between oxidative stress markers levels and Hcy levels was found in the study by Nanetti et al [26] . They suggested that Hcy levels control could positively interact with some of the pathological changes involved in the evolution of cerebral ischemic damage. Milton [4] showed that homocysteine inhibited hydrogen peroxide breakdown by catalase in human neuroblastoma cell line.
Oxidative damage is involved in the pathogenesis of primary open angle glaucoma and homocysteine has a role in the development of this type of glaucoma [27] . It has been reported that elevated homocysteine (Hcy) may activate oxidative stress and reduce bone mineral density in post-menopausal osteoporosis [28] .
The pathogenesis of various GI diseases including peptic ulcers, gastrointestinal cancers, and infl ammatory bowel disease is in part due to oxidative stress [2, 3] . Unraveling the signaling events initiated at the cellular level by oxidative free radicals as well as the physiological responses to such stress are important to better understand disease pathogenesis and to develop new therapies. Oksidativni stress igra ulogu u patogenezi brojnih gastrointestinalnih infl amatornih obolenja. Povišen nivo homocisteina može imati ulogu u patogenezi Kronove bolesti i ulceroznog kolitisa. Cilj ovog rada je da ispita uticaj homocisteina na antioksidativni status u tkivu creva i jetre pacova. U crevu i jetri pacova muškog pola praćeni su nivoi reaktivnih supstanci tiobarbiturne kiseline (TBARS), aktivnost katalaze (CAT), i totalni antioksidativni status (TAS) u kontrolnoj grupi (8 pacova) i posle tročasovne inkubacije u D,L-homocistein tiolaktonu (10μmol/L) (8 pacova). Uzorci tkiva duodenuma, ileuma, kolona i jetre su homogenizovana u fosfatnom puferu (1:10). Homogenati su centrifugirani na 10000 obrtaja 10 min na 4 0 C i supernatanti su korišćeni za biohemijske analize. Naši rezultati su pokazali da visoka koncentracija D,L-homocistein tiolaktona smanjuje aktivnost katalaze u homogenatima izolovanih segmenata duodenuma (27.04%) p<0.01; ileuma (37, 27%), kolona (34, 17%) i jetre (67, 46%) p<0.001. Izlaganje visokim koncentracijama D,L-homocistein tiolaktona značajno povećava nivo TBARS u duodenumu (106.05%), ileumu (47.24%), kolonu (112.75%) i jetri (32.07%) (p<0.01). Homocistein takođe modifi kuje totalni antioksidativni status u homogenatima duodenuma, ileuma, kolona i jetre, povećavajući ga za 20.68% (duodenum), 24.74% (ileum), 14.88% (kolon) i 19.35% (jetra) (p<0.001). Homocistein dovodi do oksidativnog stresa u tkivu creva i jetre pacova (smanjena aktivnost katalaze i povećan nivo TBARS), a povišena aktivnost TAS-a u našem eksperimentu se može objasniti kao adaptivni odgovor na stvaranje slobodnih radikala i pokazuje na neuspeh ukupnog mehanizma antioksidativne odbrane u zaštiti tkiva od oštećenja izazvanih homocisteinom.
EFEKTI AKUTNE ADMINISTRACIJE D,L-HOMOCISTEIN
